Trajectory patterns and predictors of cancer-related fatigue in postoperative lung cancer patients receiving chemotherapy
Supportive Care in Cancer · 2024
DOI: 10.1007/s00520-024-08715-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Yaqing Yuan und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Fatigue, Social Support. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: Cancer-related fatigue (CRF) is a chronic symptom that can affect the overall functioning of lung cancer patients throughout the course of the disease. However, there is limited research on the trajectory and predictors of CRF specifically in lung cancer patients. Furthermore, few studies have investigated the predictive role of positive psychological and social factors in relation to CRF. This study aimed to explore the trajectory of CRF and its predictors in postoperative chemotherapy patients with lung cancer. METHODS: A total of 202 lung cancer patients who underwent surgery and received adjuvant chemotherapy were recruited for this study. Baseline questionnaires were completed, covering sociodemographic information, disease details, CRF levels, personality traits, psychological resilience, and social support. CRF was assessed at three time points: first chemotherapy (T1), 3 months after chemotherapy (T2), and 6 months after chemotherapy (T3). Latent class growth modeling (LCGM) was used to identify distinct developmental trajectories of CRF. Logistic regression analysis was employed to examine predictors of CRF within different patient groups. RESULTS: The LCGM analysis revealed three distinct CRF trajectories: persistent high fatigue group (30.7%), rising fatigue group (30.7%), and no fatigue group (38.6%). Cancer stage (OR = 7.563, 95% CI = 2.468-23.182, P < 0.001), melancholic personality (OR = 6.901, 95% CI = 1.261-37.764, P = 0.026), and high psychological resilience (OR = 0.171, 95% CI = 0.041-0.706, P = 0.015) were associated with the CRF trajectory. On the other hand, sanguine personality (OR = 0.254, 95% CI = 0.071-0.916, P = 0.036) and high social support (OR = 0.168, 95% CI = 0.045-0.627, P = 0.008) were associated with the increasing fatigue trajectory. CONCLUSIONS: This study demonstrated that 60% of lung cancer patients experienced persistent fatigue throughout the assessment period. Moreover, it confirmed the heterogeneity of CRF trajectories among lung cancer patients. The severity of CRF was found to be higher in patients with advanced clinical stages, depressive personality traits, and lower psychological resilience.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, China.
- Department of Vascular Surgery, Shandong First Medical University Affiliated Provincial Hospital, Jinan, China.
- School of Nursing, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, China. pingpingde@126.com.
Zitieren
APA
Yuan, Y., Liu, C., Shi, W., Wang, Y., & Chen, L. (2024). Trajectory patterns and predictors of cancer-related fatigue in postoperative lung cancer patients receiving chemotherapy. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08715-9
Vancouver
Yuan Y, Liu C, Shi W, Wang Y, Chen L. Trajectory patterns and predictors of cancer-related fatigue in postoperative lung cancer patients receiving chemotherapy. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08715-9
BibTeX
@article{Yuan2024,
author = {Yuan, Yaqing and Liu, Cuiping and Shi, Wen and Wang, Ying and Chen, Liping},
title = {Trajectory patterns and predictors of cancer-related fatigue in postoperative lung cancer patients receiving chemotherapy},
journal = {Supportive Care in Cancer},
year = {2024},
doi = {10.1007/s00520-024-08715-9}
}
EUVIMED